Literature DB >> 22342092

Does the intent to irradiate the internal mammary nodes impact survival in women with breast cancer? A population-based analysis in British Columbia.

Robert A Olson1, Ryan Woods, Caroline Speers, Jeffrey Lau, Andrea Lo, Pauline T Truong, Scott Tyldesley, Ivo A Olivotto, Lorna Weir.   

Abstract

PURPOSE: To determine the value of the intent to include internal mammary nodes (IMNs) in the radiation therapy (RT) volume for patients receiving adjuvant locoregional (breast or chest wall plus axillary and supraclavicular fossa) RT for breast cancer. METHODS AND MATERIALS: 2413 women with node-positive or T3/4N0 invasive breast cancer, treated with locoregional RT from 2001 to 2006, were identified in a prospectively maintained, population-based database. Intent to include IMNs in RT volume was determined through review of patient charts and RT plans. Distant relapse free survival (D-RFS), breast cancer-specific survival (BCSS), and overall survival (OS) were compared between the two groups. Prespecified pN1 subgroup analyses were performed.
RESULTS: The median follow-up time was 6.2 years. Forty-one percent of study participants received IMN RT. The 5-year D-RFS for IMN inclusion and exclusion groups were 82% vs. 82% (p = 0.82), BCSS was 87% vs. 87% (p = 0.81), and OS was 85% vs. 83% (p = 0.06). In the pN1 subgroup, D-RFS was 90% vs. 88% (p = 0.31), BCSS was 94% vs. 92% (p = 0.18), and OS was 91% vs. 88% (p = 0.01). After potential confounding variables were controlled for, women who received IMN RT did not have significantly different D-RFS (hazard ratio [HR] = 1.02 (95% confidence interval [CI], 0.84-1.24; p = 0.85), BCSS (HR = 0.98 (95% CI, 0.79-1.22; p = 0.88), or OS (HR = 0.95; 95% CI, 0.78-1.15; p = 0.57). In the pN1 subgroup, IMN RT was associated with trends for improved survival that were not statistically significant: D-RFS (HR = 0.87; 95% CI, 0.63-1.22; p = 0.42), BCSS (HR = 0.85; 95% CI, 0.57-1.25; p = 0.39), and OS (HR = 0.78; 95% CI, 0.56-1.09; p = 0.14).
CONCLUSIONS: After a median follow-up time of 6.2 years, although intentional IMN RT was not associated with a significant improvement in survival, this population-based study suggests that IMN RT may contribute to improved outcomes in selected patients with N1 disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22342092     DOI: 10.1016/j.ijrobp.2011.11.066

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Locoregional therapy of locally advanced breast cancer: a clinical practice guideline.

Authors:  M Brackstone; G G Fletcher; I S Dayes; Y Madarnas; S K SenGupta; S Verma
Journal:  Curr Oncol       Date:  2015-03       Impact factor: 3.677

2.  Unintended irradiation of internal mammary chain - Is that enough?

Authors:  Lucas Gomes Sapienza; Michael Jenwei Chen; Maria José Leite Gomes; David B Mansur
Journal:  Rep Pract Oncol Radiother       Date:  2015-08-11

3.  Why do we need irradiation of internal mammary lymph nodes in patients with breast cancer: Analysis of lymph flow and radiotherapy studies.

Authors:  Novikov Sergey Nikolaevich; Kanaev Sergey Vasilevich
Journal:  Rep Pract Oncol Radiother       Date:  2016-10-22

4.  Unplanned irradiation of internal mammary lymph nodes in breast cancer.

Authors:  Gul Kanyilmaz; Meryem Aktan; Mehmet Koc; Hikmettin Demir; Lütfi Saltuk Demir
Journal:  Radiol Med       Date:  2017-03-03       Impact factor: 3.469

5.  Operable breast cancer of the inner hemisphere is associated with poor survival.

Authors:  Cong Xue; Rou Jun Peng; Shu Sen Wang; Yan Xia Shi; Xin An; Fei Xu; Zhong Yu Yuan
Journal:  J Breast Cancer       Date:  2015-03-27       Impact factor: 3.588

6.  Incidental irradiation of internal mammary lymph nodes in breast cancer: conventional two-dimensional radiotherapy versus conformal three-dimensional radiotherapy.

Authors:  Elton Trigo Teixeira Leite; Rafael Tsuneki Ugino; Marco Antônio Santana; Denis Vasconcelos Ferreira; Maurício Russo Lopes; Edilson Lopes Pelosi; João Luis Fernandes da Silva; Heloisa de Andrade Carvalho
Journal:  Radiol Bras       Date:  2016 May-Jun

7.  POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.

Authors:  Xu-Ran Zhao; Hui Fang; Yu Tang; Zhi-Hui Hu; Hao Jing; Lin Liang; Xue-Na Yan; Yong-Wen Song; Jing Jin; Yue-Ping Liu; Bo Chen; Yuan Tang; Shu-Nan Qi; Ning Li; Ning-Ning Lu; Kuo Men; Chen Hu; Yu-Hui Zhang; Ye-Xiong Li; Shu-Lian Wang
Journal:  BMC Cancer       Date:  2021-11-06       Impact factor: 4.430

8.  Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials.

Authors:  Wilfried Budach; Kai Kammers; Edwin Boelke; Christiane Matuschek
Journal:  Radiat Oncol       Date:  2013-11-14       Impact factor: 3.481

9.  Should internal mammary lymph node sentinel biopsy be performed in breast cancer: a systematic review and meta-analysis.

Authors:  Jing Gong; Yongfu Yu; Gaosong Wu; Congyao Lin; Xin Tu
Journal:  World J Surg Oncol       Date:  2019-08-05       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.